{"transactions":[{"id":4637890,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-08T20:30:22.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":21829,"price":0.7444,"value":16249.5076,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of board fees."}],"balance_after":80438,"source":{"system":"sec-edgar","filing":"0001193125-26-417969","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827847/000119312526417969/ownership.xml","form_type":"4"}},{"id":703099,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-27T20:15:10.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":8463,"price":1.92,"value":16248.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of board fees."}],"balance_after":58609,"source":{"system":"sec-edgar","filing":"0001193125-26-318103","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312526318103/ownership.xml","form_type":"4"}},{"id":795990,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-01T20:18:01.000Z","date":"2026-04-29","kind":"grant","planned":false,"acquired":true,"shares":6274,"price":2.59,"value":16249.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of board fees."}],"balance_after":50146,"source":{"system":"sec-edgar","filing":"0001193125-26-201489","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312526201489/ownership.xml","form_type":"4"}},{"id":938659,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-15T21:15:03.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":5622,"price":2.89,"value":16247.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of board fees."}],"balance_after":43872,"source":{"system":"sec-edgar","filing":"0001193125-26-014116","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312526014116/ownership.xml","form_type":"4"}},{"id":987517,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-27T02:26:18.000Z","date":"2025-11-21","kind":"grant","planned":false,"acquired":true,"shares":5142,"price":3.16,"value":16248.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of board fees."}],"balance_after":38250,"source":{"system":"sec-edgar","filing":"0001193125-25-301026","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312525301026/ownership.xml","form_type":"4"}},{"id":1091430,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-07-07T23:11:39.000Z","date":"2025-07-03","kind":"grant","planned":false,"acquired":true,"shares":6400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-twelfth of the Option vests each month on the monthly anniversary of July 3, 2025, with any amount that remains unvested on the date immediately preceding the Company's 2026 annual general meeting of stockholders vesting thereon."}],"balance_after":6400,"derivative":{"exercise_price":5,"expiration_date":"2035-07-03","underlying":"Common Stock","underlying_shares":6400},"source":{"system":"sec-edgar","filing":"0000950170-25-094387","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025094387/ownership.xml","form_type":"4"}},{"id":1091429,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-07T23:11:39.000Z","date":"2025-07-03","kind":"grant","planned":false,"acquired":true,"shares":4050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents a grant of restricted stock units (RSUs) which immediately vested upon grant. After the reported acquisition of the RSUs, the reporting person owned in aggregate 33,133 shares of common stock (29,083 previously owned shares, plus the instant grant of 4,034 RSUs)."}],"balance_after":33133,"source":{"system":"sec-edgar","filing":"0000950170-25-094387","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025094387/ownership.xml","form_type":"4"}},{"id":1101249,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-2 Convertible Preferred Stock","published_at":"2025-06-27T01:19:44.000Z","date":"2025-06-24","kind":"purchase","planned":false,"acquired":true,"shares":600,"price":4.49,"value":2694.0,"ownership":{"direct":false,"nature":"By Watermill Asset Management Corp"},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The preferred stock is perpetual and therefore has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by WaterMill Asset Management Corp. (\"WaterMill\"). The Reporting Person serves as the principal of WaterMill."}],"balance_after":600,"derivative":{"exercise_price":4.49,"exercise_date":"2025-06-24","underlying":"Common Stock","underlying_shares":133630.29},"source":{"system":"sec-edgar","filing":"0000950170-25-090587","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025090587/ownership.xml","form_type":"4"}},{"id":1101248,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-1 Convertible Preferred Stock","published_at":"2025-06-27T01:19:44.000Z","date":"2025-04-11","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":2.76,"value":1380.0,"ownership":{"direct":false,"nature":"By WaterMill Asset Management Corp."},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The preferred stock is perpetual and therefore has no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The reporting person disclaims beneficial ownership of these equity securities to the extent that after giving effect of the conversion of the preferred stock and the underlying common stock issuance, the reporting person would beneficially own in the aggregate in excess of 4.99% of the outstanding shares immediately after giving effect to such conversion or issuance."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by WaterMill Asset Management Corp. (\"WaterMill\"). The Reporting Person serves as the principal of WaterMill."}],"balance_after":500,"derivative":{"exercise_price":2.76,"exercise_date":"2025-04-11","underlying":"Common Stock","underlying_shares":181159},"source":{"system":"sec-edgar","filing":"0000950170-25-090587","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025090587/ownership.xml","form_type":"4"}},{"id":1101247,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-27T01:19:44.000Z","date":"2025-04-13","kind":"grant","planned":false,"acquired":true,"shares":20804,"price":2.92,"value":60747.68,"ownership":{"direct":true},"balance_after":29083,"source":{"system":"sec-edgar","filing":"0000950170-25-090587","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025090587/ownership.xml","form_type":"4"}},{"id":1172041,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-1 Convertible Preferred Stock","published_at":"2025-04-16T00:42:09.000Z","date":"2025-04-11","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":2.76,"value":1380.0,"ownership":{"direct":false,"nature":"By WaterMill Asset Management Corp."},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The preferred stock is perpetual and therefore has no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The reporting person disclaims beneficial ownership of these equity securities to the extent that after giving effect of the conversion of the preferred stock and the underlying common stock issuance, the reporting person would beneficially own in the aggregate in excess of 4.99% of the outstanding shares immediately after giving effect to such conversion or issuance."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by WaterMill Asset Management Corp. (\"WaterMill\"). The Reporting Person serves as the principal of WaterMill."}],"balance_after":500,"derivative":{"exercise_price":2.76,"exercise_date":"2025-04-11","underlying":"Common Stock","underlying_shares":181159},"source":{"system":"sec-edgar","filing":"0000950170-25-054436","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025054436/ownership.xml","form_type":"4"}},{"id":1172040,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-16T00:42:09.000Z","date":"2025-04-13","kind":"grant","planned":false,"acquired":true,"shares":20804,"price":2.92,"value":60747.68,"ownership":{"direct":true},"balance_after":29083,"source":{"system":"sec-edgar","filing":"0000950170-25-054436","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025054436/ownership.xml","form_type":"4"}},{"id":1485394,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-06-10T21:00:08.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":12800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the Option vests each month on the monthly anniversary of June 6, 2024, with any amount that remains unvested on the date immediately preceding the Company's 2025 annual general meeting of stockholders vesting thereon."}],"balance_after":12800,"derivative":{"exercise_price":1.03,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":12800},"source":{"system":"sec-edgar","filing":"0000950170-24-071399","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017024071399/ownership.xml","form_type":"4"}},{"id":1862809,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option\n(right to buy)","published_at":"2023-06-08T21:27:39.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares underlying the option vest in equal monthly installments measured from June 6, 2023, with the first vesting occurring on July 6, 2023, subject to the Reporting Person's continued service through each such date."}],"balance_after":100000,"derivative":{"exercise_price":0.48,"expiration_date":"2033-06-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-23-014923","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924323014923/doc4.xml","form_type":"4"}},{"id":2100310,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-01T21:05:19.000Z","date":"2022-11-29","kind":"purchase","acquired":true,"shares":750000,"price":0.65,"value":487500.0,"ownership":{"direct":false,"nature":"By WaterMill Asset Management Corp."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares are directly held by WaterMill Asset Management Corp. The Reporting Person serves as the principal of WaterMill Asset Management Corp."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were purchased in a registered underwritten offering on November 29, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The shares are directly held by WaterMill Asset Management Corp. The Reporting Person serves as the principal of WaterMill Asset Management Corp."}],"balance_after":5000000,"source":{"system":"sec-edgar","filing":"0000899243-22-037275","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322037275/doc4.xml","form_type":"4"}},{"id":2222284,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-06-24T20:35:17.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in twelve equal monthly installments beginning on July 13, 2022."}],"balance_after":100000,"derivative":{"exercise_price":0.82,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-22-024005","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322024005/doc4.xml","form_type":"4"}},{"id":2222283,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-24T20:35:17.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 946,970 shares of common stock underlying units of the Issuer  (the \"Units\"). Each Unit is comprised of one share of common stock and one warrant to acquire one share of common stock. The Reporting Person previously purchased 946,970 Units in a private placement transaction with the Issuer."}],"balance_after":1241870,"source":{"system":"sec-edgar","filing":"0000899243-22-024005","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322024005/doc4.xml","form_type":"4"}},{"id":2222278,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-06-24T20:31:48.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in twelve equal monthly installments beginning on July 13, 2022."}],"balance_after":100000,"derivative":{"exercise_price":0.82,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-22-023987","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322023987/doc4.xml","form_type":"4"}},{"id":2222277,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-24T20:31:48.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 946,970 shares of common stock underlying units of the Issuer  (the \"Units\"). Each Unit is comprised of one share of common stock and one warrant to acquire one share of common stock. The Reporting Person previously purchased 946,970 Units in a private placement transaction with the Issuer."}],"balance_after":1241870,"source":{"system":"sec-edgar","filing":"0000899243-22-023987","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322023987/doc4.xml","form_type":"4"}},{"id":2579936,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-03T21:22:06.000Z","date":"2021-09-02","kind":"purchase","acquired":true,"shares":54492,"price":1.73,"value":94271.16,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by WaterMill Asset Management Corp. (\"WaterMill\"). The Reporting Person serves as the principal of WaterMill."}],"balance_after":4250000,"source":{"system":"sec-edgar","filing":"0001209191-21-054825","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919121054825/doc4.xml","form_type":"4"}},{"id":2579935,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-03T21:22:06.000Z","date":"2021-09-02","kind":"purchase","acquired":true,"shares":20508,"price":1.73,"value":35478.84,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 946,970 shares of common stock underlying the Units. The Reporting Person purchased 946,970 units of the Issuer (the \"Units\") for $2.64 per Unit in a private placement transaction with the Issuer. Each Unit consists of one share of common stock and a warrant to acquire one share of common stock."}],"balance_after":1201870,"source":{"system":"sec-edgar","filing":"0001209191-21-054825","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919121054825/doc4.xml","form_type":"4"}},{"id":2725344,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-06T23:24:10.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/36th of the shares underlying this option will vest in equal monthly installments commencing one month period after 12/15/2020."}],"balance_after":150000,"derivative":{"exercise_price":4.31,"expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-21-030742","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919121030742/doc4.xml","form_type":"4"}},{"id":2725343,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-06T23:24:10.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/3rd of the shares underlying this option will vest on 4/4/2021, 5/4/2021 and 5/19/2021."}],"balance_after":18750,"derivative":{"exercise_price":4.31,"expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001209191-21-030742","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919121030742/doc4.xml","form_type":"4"}},{"id":2725342,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-06T23:24:10.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares will vest on 5/19/2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 946,970 shares of common stock underlying the Units. The Reporting Person purchased 946,970 units of the Issuer (the \"Units\") for $2.64 per Unit in a private placement transaction with the Issuer. Each Unit consists of one share of common stock and a warrant to acquire one share of common stock."}],"balance_after":1181362,"source":{"system":"sec-edgar","filing":"0001209191-21-030742","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919121030742/doc4.xml","form_type":"4"}}]}